Continuum Advisory »

Immunitybio shares owned by Continuum Advisory

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $107k 21k 5.06

More positions owned by Continuum Advisory

Apple (AAPL)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vanguard Index Fds Extend Mkt Etf (VXF)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr Ser Tr Msci Usa Strtgic (QUS)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Large Cap Etf (VV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for Continuum Advisory

Top funds holding Immunitybio

Vanguard Group
Credit Suisse
Jpmorgan Chase & Co
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Jane Street
D. E. Shaw & Co
Barclays
Citadel Advisors
Bank of New York Mellon
Bsc Private Wealth Management
Citigroup
Bank Of Montreal
Alliancebernstein

View all funds holding Immunitybio